Intrinsic Value of S&P & Nasdaq Contact Us

Fusion Pharmaceuticals Inc. FUSN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • CA • USD

SharesGrow Score
30/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$15.25
-29.2%

Fusion Pharmaceuticals Inc. (FUSN) has 20 known insider and institutional holders on record. The largest holder is Christenson Johan with 576,233 shares. Other notable holders include ADAMS STREET PARTNERS LLC and Valliant John.

FUSN Insider Ownership

Top Holder
Christenson Johan
576,233 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Christenson Johan Director 576,233 2020-06-30
100%
2 Adams Street Partners Llc 10 Percent Owner 418,190 2020-12-29
73%
3 Valliant John Chief Executive Officer 192,200 2024-01-05
33%
4 Bobilev Dmitri Chief Medical Officer 91,000 2024-01-05
16%
5 Burak Eric Chief Technology Officer 63,700 2024-01-05
11%
6 Crowley John J Chief Financial Officer 63,700 2024-01-05
11%
7 Meek David D. Director 34,000 2023-10-16
6%
8 Bender Jeremy Director 34,000 2023-10-16
6%
9 Bitetti Teresa Marie Director 34,000 2023-10-16
6%
10 Lamb Damian Director 30,000 2020-06-30
5%
11 Bergstrom Donald A Director 17,000 2023-06-14
3%
12 Gannon Steven Director 17,000 2023-06-14
3%
13 Duncan Barbara Gayle Director 17,000 2023-06-14
3%
14 Preston Heather Director 17,000 2023-06-14
3%
15 Cagnoni Pablo J Director 17,000 2023-06-14
3%
16 Lee Philina Director 17,000 2023-06-14
3%
17 Khuong Chau Quang Director 17,000 2023-06-14
3%
18 Rawat Mohit President & Cbo 12,843 2024-01-05
2%
19 Leamon Christopher P Chief Scientific Officer 11,957 2024-01-05
2%
20 O'leary James J Chief Medical Officer 2,022 2022-02-03
0%

No ownership data available for FUSN.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message